◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Telo Genomics Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 0.00 --
Selling General And Administration 247,370 359,192 494,201 248,541 207,656 --
General And Administrative Expense 247,370 359,192 494,201 248,541 207,656 --
Research And Development 294,315 308,915 351,508 387,261 345,108 --
Other Operating Expenses -- -- -600.00 -21,585 -- --
Operating Expense 541,685 690,292 845,109 614,217 552,764 --
Operating Income -541,685 -690,292 -845,109 -614,217 -552,764 --
EBIT -541,685 -690,292 -845,109 -614,217 -552,764 --
Other Income Expense -- -- -- -- -- 0.00
Special Income Charges -- -16,371 0.00 -- -- 0.00
Pretax Income -541,685 -706,663 -845,109 -614,217 -552,764 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -541,685 -706,663 -845,109 -614,217 -552,764 --
Net Income From Continuing Operation Net Minority Interest -541,685 -706,663 -845,109 -614,217 -552,764 --
Net Income Including Noncontrolling Interests -541,685 -706,663 -845,109 -614,217 -552,764 --
Net Income Common Stockholders -541,685 -706,663 -845,109 -614,217 -552,764 --
Net Income -541,685 -706,663 -845,109 -614,217 -552,764 --
EBITDA -538,922 -687,412 -842,229 -610,935 -547,354 --
Normalized EBITDA -538,922 -671,041 -842,229 -610,935 -547,354 --
Reconciled Depreciation 2,763 2,880 2,880 3,282 5,410 --
Basic EPS -0.01 -- -0.01 -0.01 -0.01 --
Diluted EPS -0.01 -- -0.01 -0.01 -0.01 --
Basic Average Shares 100.4M -- 100.0M 76.8M 74.6M --
Diluted Average Shares 100.4M -- 100.0M 76.8M 74.6M --
Total Unusual Items -- -16,371 0.00 -- -- 0.00
Total Unusual Items Excluding Goodwill -- -16,371 0.00 -- -- 0.00
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income -541,685 -690,292 -845,109 -614,217 -552,764 --
Diluted NI Availto Com Stockholders -541,685 -706,663 -845,109 -614,217 -552,764 --
Net Income Continuous Operations -541,685 -706,663 -845,109 -614,217 -552,764 --
Other Gand A 247,370 359,192 494,201 248,541 207,656 --
Other Special Charges -- -- -- -- -- 0.00
Total Expenses 541,685 690,292 845,109 614,217 552,764 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 486,508 789,293 1.2M 2.2M 328,272 --
Cash Cash Equivalents And Short Term Investments 486,508 789,293 1.2M 2.2M 328,272 --
Cash Financial 486,508 789,293 1.2M 2.2M -- 796,020
Accounts Receivable 16,801 26,539 30,411 29,526 17,487 --
Receivables 16,801 26,539 30,411 29,526 17,487 --
Prepaid Assets 85,237 76,430 80,232 36,745 53,223 --
Current Assets 588,546 892,262 1.4M 2.3M 398,982 --
Gross PPE 952,147 950,072 950,072 946,822 946,822 --
Accumulated Depreciation -933,797 -931,034 -928,154 -925,274 -921,992 --
Net PPE 18,350 19,038 21,918 21,548 24,830 --
Goodwill And Other Intangible Assets 0.00 0.00 16,371 16,371 16,371 --
Other Intangible Assets -- -- 16,371 16,371 -- --
Total Non Current Assets 18,350 19,038 38,289 37,919 41,201 --
Total Assets 606,896 911,300 1.4M 2.4M 440,183 --
Payables And Accrued Expenses 633,600 396,319 274,562 603,769 403,065 --
Current Liabilities 633,600 396,319 274,562 603,769 403,065 --
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 0.00 --
Total Liabilities Net Minority Interest 633,600 396,319 274,562 603,769 403,065 --
Common Stock 24.6M 24.6M 24.6M 24.6M 22.3M --
Capital Stock 24.6M 24.6M 24.6M 24.6M 22.3M --
Additional Paid In Capital 6.4M 6.4M 6.4M 6.2M 6.1M --
Retained Earnings -31.1M -30.5M -29.8M -29.0M -28.4M --
Common Stock Equity -26,704 514,981 1.1M 1.7M 37,118 --
Stockholders Equity -26,704 514,981 1.1M 1.7M 37,118 --
Total Equity Gross Minority Interest -26,704 514,981 1.1M 1.7M 37,118 --
Total Capitalization -26,704 514,981 1.1M 1.7M 37,118 --
Net Tangible Assets -26,704 514,981 1.1M 1.7M 20,747 --
Tangible Book Value -26,704 514,981 1.1M 1.7M 20,747 --
Working Capital -45,054 495,943 1.1M 1.7M -4,083 --
Invested Capital -26,704 514,981 1.1M 1.7M 37,118 --
Share Issued 100.4M 100.0M 100.0M 100.0M 74.6M --
Ordinary Shares Number 100.4M 100.0M 100.0M 100.0M 74.6M --
Machinery Furniture Equipment 952,147 950,072 950,072 946,822 946,822 --
Other Equity Interest -- 50,369 25,753 -- -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -300,710 -459,402 -995,967 -405,792 -467,573 --
Cash Flow From Continuing Operating Activities -300,710 -459,402 -995,967 -405,792 -467,573 --
Depreciation And Amortization 2,763 2,880 2,880 3,282 5,410 --
Depreciation Amortization Depletion 2,763 2,880 2,880 3,282 5,410 --
Stock Based Compensation -- 73,963 194,088 0.00 0.00 -38,264
Change In Working Capital 238,212 129,431 -373,579 205,143 79,781 --
Change In Receivables 9,738 3,872 -885.00 -12,039 13,762 --
Change In Payables And Accrued Expense 237,281 121,756 -329,206 200,704 27,478 --
Other Non Cash Items -- 24,616 -- -- -- --
Capital Expenditure -2,075 -- -- -- -- -2,315
Purchase Of PPE -2,075 0.00 -3,250 0.00 0.00 --
Net PPE Purchase And Sale -2,075 0.00 -3,250 0.00 0.00 --
Investing Cash Flow -2,075 0.00 -3,250 0.00 0.00 --
Cash Flow From Continuing Investing Activities -2,075 0.00 -3,250 0.00 0.00 --
Repayment Of Debt -- 0.00 -- -- -- 0.00
Net Issuance Payments Of Debt -- 0.00 -- -- -- 0.00
Issuance Of Capital Stock -- 0.00 0.00 -- -- --
Net Common Stock Issuance -- 0.00 0.00 -- -- --
Financing Cash Flow -- 0.00 -491.00 2.3M -175.00 611,834
Cash Flow From Continuing Financing Activities -- 0.00 -491.00 2.3M -175.00 611,834
Changes In Cash -302,785 -459,402 -999,708 1.9M -467,748 --
Beginning Cash Position 789,293 1.2M 2.2M 328,272 796,020 --
End Cash Position 486,508 789,293 1.2M 2.2M 328,272 --
Free Cash Flow -302,785 -459,402 -999,217 -405,792 -467,573 --
Change In Prepaid Assets -8,807 3,803 -43,488 16,478 38,541 --
Common Stock Issuance -- 0.00 0.00 -- -- --
Depreciation 2,763 2,880 2,880 3,282 5,410 --
Long Term Debt Payments -- 0.00 -- -- -- 0.00
Net Income From Continuing Operations -541,685 -706,663 -845,109 -614,217 -552,764 --
Net Long Term Debt Issuance -- 0.00 -- -- -- 0.00
Net Other Financing Charges -- 0.00 -491.00 -219,977 -175.00 -38,166
Operating Gains Losses -- -- -- -- -- 0.00
Proceeds From Stock Option Exercised -- -- -- -- -- 0.00
NEWS
Loading news...
TRENDING
Loading...